{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:bupivacaine-hydrochloride-injection",
  "slug": "bupivacaine-hydrochloride-injection",
  "title": "FDA shortage status: Bupivacaine Hydrochloride Injection",
  "ingredient": "Bupivacaine Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "BUPIVACAINE HYDROCHLORIDE",
    "BUPIVACAINE SPINAL",
    "MARCAINE",
    "MARCAINE SPINAL",
    "SENSORCAINE",
    "SENSORCAINE MPF"
  ],
  "therapeutic_categories": [
    "Analgesia/Addiction",
    "Anesthesia"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "EPIDURAL",
    "INFILTRATION",
    "INTRACAUDAL",
    "PERINEURAL",
    "RETROBULBAR",
    "SUBARACHNOID"
  ],
  "package_count": 61,
  "packages": [
    {
      "package_ndc": "31722-275-32",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "31722-275-34",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "31722-276-32",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "31722-276-34",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "31722-277-32",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "31722-277-34",
      "product_ndc": "31722-275",
      "company_name": "Aspiro Pharma Limited",
      "manufacturer_name": "Camber Pharmaceuticals, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "07/17/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-167-10",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-168-30",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-249-50",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-169-10",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-170-30",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-250-50",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-171-10",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-172-30",
      "product_ndc": "55150-167",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-464-17",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-464-31",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-464-37",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-465-57",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-466-17",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-466-31",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-466-37",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-467-57",
      "product_ndc": "63323-460",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-472-17",
      "product_ndc": "63323-461",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-472-37",
      "product_ndc": "63323-461",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1159-10",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1160-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1162-02",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1165-02",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1159-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1163-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1162-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1165-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1159-02",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "INTRACAUDAL",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3613-01",
      "product_ndc": "0409-3613",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "SUBARACHNOID"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1761-10",
      "product_ndc": "0409-1761",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "SUBARACHNOID"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1761-62",
      "product_ndc": "0409-1761",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "SUBARACHNOID"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1160-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1560-29",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2253-01",
      "product_ndc": "0409-0525",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1559-10",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1560-10",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1165-01",
      "product_ndc": "0409-1159",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "RETROBULBAR"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1559-30",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "73293-0002-2",
      "product_ndc": "73293-0002",
      "company_name": "Huons Co., Ltd",
      "manufacturer_name": "Huons Co., Ltd.",
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "SUBARACHNOID"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-722-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "05/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-722-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-723-52",
      "product_ndc": "71288-723",
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "05/05/2026",
      "initial_posting_date": "05/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-723-52",
      "product_ndc": "71288-723",
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "05/05/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-725-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "05/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-725-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-726-52",
      "product_ndc": "71288-723",
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "PERINEURAL"
      ],
      "update_date": "05/05/2026",
      "initial_posting_date": "05/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-726-52",
      "product_ndc": "71288-723",
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "PERINEURAL"
      ],
      "update_date": "05/05/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-728-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "05/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-728-32",
      "product_ndc": null,
      "company_name": "Kindos Pharmaceuticals Co. Ltd.",
      "manufacturer_name": null,
      "presentation": "Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "05/05/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72266-263-10",
      "product_ndc": "72266-263",
      "company_name": "ONESOURCE SPECIALTY PTE LTD",
      "manufacturer_name": "Fosun Pharma USA Inc.",
      "presentation": "Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL (NDC 72266-263-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-752-01",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-752-10",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-752-25",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-753-01",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-753-10",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-753-25",
      "product_ndc": "70069-752",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/20/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 45,
    "Limited Availability": 6,
    "Unavailable": 5
  },
  "initial_posting_date": "02/20/2018",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}